© 2021 MJH Life Sciences and Practical Cardiology. All rights reserved.
© 2021 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
February 26, 2021
February 25, 2021
February 24, 2021
February 23, 2021
Coverage of the annual AHA Scientific Sessions
An observational analysis of data from more than 120k patients provides an overview of cerebral embolic protection devices and risk of in-hospital stroke among patients undergoing TAVR.
Dr. Gregory Weiss offers his thoughts on the most clinically impactful studies related to COVID-19 and cardiology released in the past year from his perspective as a critical care cardiologist.
February 22, 2021
Analysis of data from a 12-week study by investigators in Australia suggests testosterone therapy was not associated with improvements in arterial health or function.
February 20, 2021
An analysis of more than 2k mother-child dyads suggests assessments of cardiovascular health could provide insight into the health of offspring during adolescence.
February 19, 2021
An analysis of data from the APPROACH registry suggest early revascularization with CABG or PCI may be a more effective approach than medical therapy in patients with stable ischemic heart disease and high-risk cardiac anatomy.
February 18, 2021
An analysis of nearly 150 patients with severe COVID-19 and increased troponin levels indicates more than half of those patients went on to develop infarction, myocarditis, ischemia, or a combination of the three.
February 17, 2021
Check out our latest case report from Brady Pregerson, MD, which features a man in his 70s who recently recovered from COVID-19. Can you determine the correct diagnosis?
February 16, 2021
Novartis announced the US FDA has expanded the label for sacubitril/valsartan (Entresto) to include reducing the risk of CV death and hospitalizations for heart failure among patients with chronic heart failure.
With a backdrop of American Heart Month, Arnold Meshkov, MD, reflects on the history of cholesterol and advances in the treatment of cholesterol disorders throughout history.
An intervention trial from Germany suggests specialized mobile stroke units could help improve rates of disability and death following a stroke.
February 15, 2021
An analysis of more than 28k incident myocardial infarction events demonstrates increased physical activity levels were associated with a 21-45% lower risk of instant death and a 15-36% lower risk of death in the first 28 days.
February 13, 2021
A recent study from Northwestern University suggests 30-53% of all new diabetes cases in the United States were directly attributable to obesity.
February 12, 2021
An analysis of data from 195 countries over a nearly 3 decade period indicates prevalence and burden of heart failure have continued to grow since 1990.
February 11, 2021
A statement from Regeneron announced their ANGPTL3 inhibitor evinacumab (Evkeeza) received approval as an adjunct therapy for lowering LDL-C in patients 12 years and older with homozygous familial hypercholesterolemia.
An analysis of data from the International Consortium of Blood Pressure-Genome Wide Association Studies suggests every 1 mmHg increase in blood pressure was linked to a 1.4-2.6% increase in risk of atrial fibrillation.
February 10, 2021
Data from an analysis of nearly 400k older patients suggests Medicare Advantage beneficiaries were less likely than their counterparts with commercial insurance to be prescribed newer glucose-lowering agents such as GLP-1RAs and SGLT2 inhibitors.